FTI Incorporation Leads the Way in Particle Contamination Testing and Certified Visual Inspectors in India

1. FTI Incorporation Leads the Way in Particle Contamination Testing and Certified Visual Inspectors in India Gandhinagar, India | New Jersey, USA | Amsterdam, Europe – [20-07-2025] FTI Incorporation, a pioneer in forensic technology and pharmaceutical inspection solutions, is setting new industry benchmarks in Particle contamination testing India and providing globally recognized Certified Visual Inspectors India to meet the growing demands of pharmaceutical and life sciences sectors. With its presence across India, the USA, and Europe, the company continues to champion safety, compliance, and technological innovation in quality assurance and contamination control. FTI Incorporation is incubated at the National Forensic Sciences University (NFSU), Gandhinagar, Gujarat — India’s premier institute for forensic and scientific innovation. Leveraging academic research, industrial collaboration, and advanced AI-driven platforms, FTI delivers world-class solutions that are critical to pharmaceutical product safety, integrity, and global regulatory compliance. Rising Demand for Particle Contamination Testing in India As injectable pharmaceuticals become increasingly common in India’s pharmaceutical production lines, ensuring particle-free drug delivery has become essential. Regulatory authorities including the US FDA, EMA, and CDSCO have intensified scrutiny on foreign particulate matter in drug products — particularly sterile injectables. Recognizing this need, FTI Incorporation offers robust, reliable, and validated services for Particle contamination testing India to meet domestic and international standards. FTI’s state-of-the-art laboratories in India are equipped with advanced particle analysis tools, including light obscuration systems, membrane filtration units, microscopic analysis platforms, and dynamic image analyzers. These technologies help detect and quantify particulate contamination across a wide range of drug formats, including ampoules, vials, syringes, and infusion bags. “Particulate matter in injectables poses severe risks to patient health and regulatory compliance. Our mission is to support pharmaceutical companies in India with precise, high-throughput Particle contamination testing India services that comply with USP <788>, <789>, and European Pharmacopoeia standards,” said a Senior Scientist at FTI Incorporation.

2. Beyond testing, FTI also provides root cause analysis, contamination source tracking, and cleanroom contamination assessments to help manufacturers identify and eliminate the source of particulate intrusion, whether it’s from packaging, raw materials, manufacturing processes, or operator practices. Training the Next Generation of Certified Visual Inspectors in India Manual visual inspection remains a vital component of pharmaceutical quality control — especially for parenteral drug products. However, this process requires skill, consistency, and in-depth knowledge to ensure accurate detection of defects such as particles, fill volume discrepancies, seal issues, or cosmetic flaws. FTI Incorporation addresses this industry need by offering nationally and internationally recognized programs for Certified Visual Inspectors India. FTI's visual inspection training curriculum is designed in line with WHO, GMP, and FDA expectations. Through both theoretical instruction and hands-on training modules, professionals are taught how to conduct inspection under controlled lighting, standardized conditions, and calibrated systems. Upon successful completion, individuals are certified as competent visual inspectors — equipped to work in regulated facilities, perform inspection validations, and support quality release decisions. “Our Certified Visual Inspectors India program is bridging a major skill gap in the Indian pharma industry. As visual inspection continues to be a regulatory focal point, companies must ensure their inspectors are trained, certified, and routinely qualified. FTI is proud to offer this capability at a global standard,” said the Training Coordinator at FTI Incorporation. The program has already trained and certified professionals from leading pharmaceutical firms, contract manufacturing organizations (CMOs), and biotech companies. FTI also conducts periodic qualification tests, re-certification programs, and customized on-site training tailored to each facility's specific needs. Technological Edge and Regulatory Readiness FTI Incorporation has built its reputation on the convergence of cutting-edge technology, scientific precision, and compliance expertise. Whether it’s high- resolution camera-based inspection platforms, data-driven analytics, or AI-assisted quality control, the company’s solutions are designed to reduce human error, improve product safety, and meet evolving regulatory expectations. The company's laboratories and systems are validated as per ICH Q9, Q10, and 21 CFR Part 11 guidelines — making them suitable for use in FDA-inspected and EU- GMP certified environments. Its inspection and testing reports are routinely accepted by regulatory authorities during audits and submissions.

3. With the global focus on data integrity, FTI's inspection platforms also provide electronic batch records, image capture, and audit trail functionalities that support transparency and traceability. Global Presence, Local Expertise FTI Incorporation’s operational model bridges global expertise with local execution. The company maintains regional support offices in: India: Forensic Technological Innovation, Incubated at National Forensic Sciences University, Sector 9, Gandhinagar, Gujarat 382007 USA: 58 Albert Ct, Randolph, New Jersey – 07869 Europe: Jisperveldstaart, 1024AT, Amsterdam From these offices, FTI provides direct consultation, technical support, on-site system implementation, and customer service to clients across continents. The company's strong academic affiliations and strategic partnerships also make it a go- to knowledge hub for regulators, scientists, and pharmaceutical leaders. Commitment to Pharmaceutical Excellence FTI Incorporation’s broader vision is to foster a safer, more compliant pharmaceutical manufacturing environment — where patient safety and product integrity are non- negotiable. Through a combination of high-quality testing services, expert human resources, and AI-based technologies, FTI empowers its clients to meet and exceed national and international expectations. Its services are actively used in pharmaceutical sectors including sterile injectables, biosimilars, vaccines, oncology products, ophthalmic solutions, and parenteral nutrition — where particulate control and defect-free packaging are critical. “Our expansion in Particle contamination testing India and deployment of Certified Visual Inspectors India is not just about business growth. It’s about raising industry standards, training skilled professionals, and ensuring that every dose delivered is safe and defect-free,” said the Director of FTI Incorporation. Contact Information For all inquiries, partnerships, and support, please reach out to us: Phone: ? +91 8200487148 | +91 9638344845 Email: ✉️ Info@ftinfsu.org | fti.nfsu@gmail.com Website: ? www.ftinfsu.com

4. Indian Headquarters: Forensic Technological Innovation Incubated at National Forensic Sciences University Sector 9, Gandhinagar, Gujarat – 382007 India USA Office: 58 Albert Ct Randolph, New Jersey – 07869 USA Europe Office: Jisperveldstaart 1024AT Amsterdam Netherlands About FTI Incorporation FTI Incorporation is a global leader in pharmaceutical visual inspection, contamination testing, forensic analytics, and regulatory compliance. With cutting- edge laboratories, AI-enabled technologies, and a skilled team of scientists and inspectors, FTI is transforming how the industry addresses product quality and compliance challenges. Incubated at the National Forensic Sciences University, the company is at the intersection of science, innovation, and safety.